Filing Flows › Xwell (XWEL) › Q1 2026 › vs Q1 2025
Xwell (XWEL) Q1 2026 vs Q1 2025 (year over year)
Xwell's revenue fell $385K (-5%) from $7.0M in Q1 2025 to $6.6M in Q1 2026. The biggest changes: XpresTest −$260K (-12%); XpresSpa −$97K (-2%); Naples Wax −$28K (-5%).
Xwell, Q1 2026: revenue $6.6M (-6% year over year), operating margin -81.6%, net loss $11.0M, operating cash flow −$4.6M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| XpresSpa | $4.2M | $4.3M | −$97K | -2% |
| XpresTest | $1.9M | $2.2M | −$260K | -12% |
| Naples Wax | $524K | $552K | −$28K | -5% |
| Revenue | $6.6M | $7.0M | −$385K | -5% |
| Net loss | $11.0M | $4.6M | $6.4M | +140% |
| Costs & expenses | $17.6M | $11.6M | $6.0M | +52% |
| Operating costs | $12.1M | $10.2M | $1.9M | +18% |
| Interest & other, net | $5.6M | $1.4M | $4.2M | +291% |
| Cost of revenue | $4.3M | $5.7M | −$1.4M | -25% |
| SG&A | $7.6M | $4.3M | $3.3M | +76% |
| Other operating costs | $172K | $166K | $6K | +4% |
| Operating cash sources | $11.0M | $4.6M | $6.4M | +140% |
| Depreciation & amortization | $172K | $166K | $6K | +4% |
| Share-based compensation | $886K | $83K | $803K | +967% |
| Working capital & other | $5.4M | $161K | $5.2M | 33× |
| Cash used in operations | $4.6M | $4.2M | $424K | +10% |
| Net loss absorbed | $11.0M | $4.6M | $6.4M | +140% |
Questions
How much did Xwell's revenue grow year over year in Q1 2026?
Xwell's revenue fell $385K (-5%) from $7.0M in Q1 2025 to $6.6M in Q1 2026.
What drove Xwell's revenue change in Q1 2026?
XpresTest −$260K (-12%); XpresSpa −$97K (-2%); Naples Wax −$28K (-5%).